Discrepancies between the stated contents and analytical findings for electronic cigarette liquid products: Identification of the new cannabinoid, Δ 9 ‐tetrahydrocannabihexol acetate
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Shimpei Watanabe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Forensic Science Group, Photon Science Research Division, RIKEN SPring-8 Center, Sayo, Japan. Hauptthemen laut MEDLINE: Cannabinoids, Electronic Nicotine Delivery Systems, Illicit Drugs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: JSPS KAKENHI, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
A number of synthetic cannabinoids have been appearing in the recreational drug market for more than a decade. Recent additions are so‐called semi‐synthetic cannabinoids, and they structurally closely resemble the main psychoactive component of cannabis, Δ 9 ‐tetrahydrocannabinol. Knowledge of new (semi‐)synthetic cannabinoids is essential to help identify them in authentic forensic case samples. Therefore, the aim of the study was to examine two commercially available electronic cigarette liquid products claiming to contain cannabinoids and characterize the structures of the main compounds. The liquid products were analyzed by gas chromatography–mass spectrometry (GC–MS), GC–quadrupole time‐of‐flight mass spectrometry (GC‐QTOF‐MS), and liquid chromatography–high‐resolution mass spectrometry (LC–HRMS). In product A, typical cannabinoids (cannabidiol, cannabigerol, and cannabinol) and terpenes (α‐caryophyllene and β‐caryophyllene) were identified by comparison with reference materials. An unknown peak was isolated by semi‐preparative high‐performance LC, analyzed by nuclear magnetic resonance (NMR) spectroscopy, and identified to be Δ 9 ‐tetrahydrocannabihexol acetate (Δ 9 ‐THCH‐O). To the authors' knowledge, this is the first report of the identification of Δ 9 ‐THCH‐O in commercially available products. Another compound estimated as cannabihexol acetate was also detected. In product B, cannabidiol, cannabinol, α‐caryophyllene, and β‐caryophyllene were identified, while two unknown peaks were estimated as tetrahydrocannabidiol isomers. Despite products A and B being labeled to contain “60% HHCPM” and “80% 10‐OH‐HHC,” respectively, no such compounds were detected. The findings of this study could help detect Δ 9 ‐THCH‐O in case samples and highlight the need to keep monitoring commercial products to identify new drugs, while warning that the package labels cannot be trusted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Forensic Science Group, Photon Science Research Division, RIKEN SPring-8 Center, Sayo, Japan.
- Forensic Science Laboratory, Ishikawa Prefectural Police Headquarters, Kanazawa, Japan.
- Institute of Science and Engineering, Kanazawa University, Kanazawa, Japan.
ORCID-Profile: Shimpei Watanabe, Takaya Murakami
Förderung
- JSPS KAKENHI
- Japan Society for the Promotion of Science
Zitieren
APA
Watanabe, S., Murakami, T., Muratsu, S., Fujiwara, H., Nakanishi, T., & Seto, Y. (2025). Discrepancies between the stated contents and analytical findings for electronic cigarette liquid products: Identification of the new cannabinoid, Δ 9 ‐tetrahydrocannabihexol acetate. Drug Testing and Analysis. https://doi.org/10.1002/dta.3777
Vancouver
Watanabe S, Murakami T, Muratsu S, Fujiwara H, Nakanishi T, Seto Y. Discrepancies between the stated contents and analytical findings for electronic cigarette liquid products: Identification of the new cannabinoid, Δ 9 ‐tetrahydrocannabihexol acetate. Drug Testing and Analysis. 2025. doi:10.1002/dta.3777
BibTeX
@article{Watanabe2025,
author = {Watanabe, Shimpei and Murakami, Takaya and Muratsu, Seiji and Fujiwara, Hiroyuki and Nakanishi, Toshio and Seto, Yasuo},
title = {Discrepancies between the stated contents and analytical findings for electronic cigarette liquid products: Identification of the new cannabinoid, Δ 9 ‐tetrahydrocannabihexol acetate},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3777}
}
EUVIMED